Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
about
Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in miceNoninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.Mechanistic modelling of dynamic MRI data predicts that tumour heterogeneity decreases therapeutic response.Single-shot T1 mapping using simultaneous acquisitions of spin- and stimulated-echo-planar imaging (2D ss-SESTEPI).An extracellular MRI polymeric contrast agent that degrades at physiological pHVisualizing vascular permeability and lymphatic drainage using labeled serum albuminIn vivo small animal imaging: current status and future prospects.Could magnetic resonance provide in vivo histology?Multiparametric MRI in prostate cancer management.The biodistribution of [153Gd]Gd-labeled magnetic resonance contrast agents in a transgenic mouse model of renal failure differs greatly from control mice.Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.Anti-angiogenic Effects of Bumetanide Revealed by DCE-MRI with a Biodegradable Macromolecular Contrast Agent in a Colon Cancer ModelContrast agents in dynamic contrast-enhanced magnetic resonance imaging.Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats.Assessment of Blood Brain Barrier Leakage with Gadolinium-Enhanced MRI.Non-invasive quantification of anti-angiogenic therapy by contrast-enhanced MRI in experimental pancreatic cancer.Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.Vascular endothelial growth factor antisense oligonucleotides inhibit leptomeningeal metastasis in vivo.
P2860
Q33486630-2197E895-4960-4F72-88DB-23509F28D901Q33584677-0A1033C7-8097-4DD6-B878-94C81B529B2EQ33625077-3D33DF9A-809D-466D-A2C1-741F9621D42CQ33632105-3EC17C4F-8D84-494F-A4EC-838F274A5036Q34966357-9A0B0D00-6C8D-4F1F-A24F-B9464E761A6AQ36236679-B24152A2-6F02-422E-B24F-F939D6AE1ECBQ37761659-7874A4F7-A0C7-45DB-8A95-79DDADB33F87Q37837837-EF3E2848-5C3D-47EA-8CA8-4F6C635C0FEFQ38181079-F88F4F24-8AC3-40B2-AE2B-227D6661FFEBQ38212715-91D45288-5501-4F52-9F68-28A4771C4F88Q38570145-916D51B7-A64E-4DCB-A472-8EC654B85CACQ38721755-2C0710B4-1768-4D37-8827-367F1D6D95C8Q38891146-7F07BDC7-F7E6-491E-9C82-51C76A2D0540Q39246340-3501DC77-CFDC-4FA9-AD0A-65325CECFF3DQ42578376-5619524D-2542-483E-9252-FE87661DF747Q47860539-916302AD-009C-46EC-A4DF-656B7CB5F06DQ47920335-00DF3525-143F-4ADB-9977-88F9FC684428Q52654441-44803223-A449-41EC-8C19-38E9D824FCF3Q53293284-F233848E-0BD8-4453-BBF2-9CC8D87A65F4
P2860
Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of tumor angi ...... cular contrast agents in mice.
@en
Characterization of tumor angi ...... cular contrast agents in mice.
@nl
type
label
Characterization of tumor angi ...... cular contrast agents in mice.
@en
Characterization of tumor angi ...... cular contrast agents in mice.
@nl
prefLabel
Characterization of tumor angi ...... cular contrast agents in mice.
@en
Characterization of tumor angi ...... cular contrast agents in mice.
@nl
P2093
P2860
P356
P1476
Characterization of tumor angi ...... cular contrast agents in mice.
@en
P2093
Eun-Kee Jeong
Lyska Emerson
Zheng-Rong Lu
P2860
P304
P356
10.1002/MRM.21791
P577
2008-12-01T00:00:00Z